Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Operational Other
confidence 72%
filed 2026-09-28
Item 8.01
DeFi Development Corp. disclosed a material update to its SOL treasury holdings, reporting growth from 2,490,304 to 2,538,010 SOL (a 2% weekly increase and 10% growth since August 12, 2026). While this is a financial metric, it reflects the company's core operational strategy of accumulating and deploying SOL through staking and validator infrastructure. The disclosure emphasizes the company's treasury strategy and capital deployment plans rather than a discrete financial event like debt issuance or dividend distribution, making it an operational/strategic business update material to investors assessing the company's execution on its stated SOL accumulation thesis.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 7.01
Quantum-Si disclosed interim development results for its next-generation Proteus platform presented at World HUPO 2026, demonstrating significant performance improvements over its commercially available Platinum Pro instrument across sequencing metrics. This is a material operational/product development disclosure showing progress toward a Q2 2027 launch, but it does not fit neatly into earnings_release (no financial results), ma_activity, or other specific categories—it is a strategic product milestone and technology demonstration that would affect investor assessment of the company's product roadmap and competitive positioning.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-28
Item 5.02
Humacyte appointed Scott Coward and Paul Kuznik to its Board of Directors on September 22, 2026. Both appointees bring substantial experience in life sciences commercialization and enterprise leadership relevant to the company's commercial-stage biotech operations and planned product launches.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-28
Item 2.03
Wintergreen Acquisition Corp. issued an unsecured promissory note in the principal amount of $184,635 to its sponsor MACRO DREAM Holdings Limited. Although non-interest-bearing and conditionally forgiven if no business combination occurs, the note represents a material direct financial obligation affecting the company's capital structure and liquidity during the extension period.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-28
Item 3.02
Wintergreen Acquisition Corp. completed an unregistered sale of equity securities involving a convertible note with underlying units issuable upon conversion, subject to transfer restrictions on the sponsor's securities until completion of the business combination and registration rights.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-28
Item 8.01
The company extended the Business Combination Deadline from September 30, 2026 to October 30, 2026 for its previously announced merger with KIKA Technology Inc. under a Merger Agreement dated November 17, 2025, demonstrating continued pursuit of the material acquisition.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-28
Item 7.01
NeOnc announced a scheduled FDA End-of-Phase 1 Type B meeting for NEO212 on November 17, 2026, to discuss Phase 2 study design and regulatory pathways. This is a material regulatory milestone for a clinical-stage biopharmaceutical company, as FDA feedback on trial design and potential accelerated approval pathways directly affects the company's development strategy and commercial prospects. The disclosure does not fit specific categories (not earnings, M&A, impairment, litigation, or debt-related), making it an operational/strategic regulatory event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-09-28
Item 2.02
This is a clear earnings release disclosing fiscal year 2026 financial results for Exascale Labs Holdings Inc. The Item 2.02 section explicitly states "On September 28, 2026, Exascale Labs Holdings Inc. issued a press release announcing financial results for its fiscal year ended June 30, 2026," with the full press release furnished as Exhibit 99.1. The exhibit contains consolidated statements of operations and balance sheets, revenue growth of 111% to $14.8 million, gross profit, operating expenses, and net loss figures—all hallmarks of an earnings release. This is material to investors as it discloses the company's first full-year results as a newly public company (listed on Nasdaq on August 28, 2026).
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-09-28
Item 3.01
Nexalin received a Notice from Nasdaq's Hearings Panel on September 25, 2026, granting conditional continued listing subject to demonstrating compliance with the Minimum Bid Price Requirement by September 28, 2026, and the Stockholders' Equity Requirement by January 4, 2027. The filing explicitly states that "if the Company fails to satisfy the conditions of the Notice, the Company's common stock will be subject to delisting from Nasdaq," and notes there is "no assurance" the Company will meet these conditions. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-28
Item 1.01
Futurewave Acquisition Corp (SPAC) entered into a definitive Agreement and Plan of Merger with Olympian Group Inc., a Hong Kong-based integrated chip and electronic component solutions provider, valuing Olympian at $400 million (40 million shares at $10.00 per share). The transaction is structured as a two-step merger resulting in Olympian becoming a wholly owned subsidiary of the surviving entity, with the combined company expected to be listed on Nasdaq and requiring shareholder approval and SEC registration on Form F-4.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-09-28
EX-99.1
This exhibit is a press release announcing Waldencast plc's first half 2026 financial results, dated September 28, 2026. It discloses net revenue from continuing operations of $26.1 million (down 57.1% YoY), net loss from continuing operations of $94.9 million (up 96.5% YoY), and a $52.3 million goodwill impairment charge against Milk Makeup. The release includes detailed financial highlights, a shareholder letter, and forward-looking strategy. While the exhibit also discusses the completed sale of Obagi Medical (a material M&A event), the primary disclosure vehicle and structure is a financial results announcement for the six-month period ended June 30, 2026, making this an earnings_release rather than a periodic report.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-28
Item 1.02
Cycurion terminated its Equity Purchase Agreement with Yield Point NY LLC effective September 25, 2026, pursuant to Section 10.6 for convenience. The agreement, originally entered into in April 2025, was terminated without operational disagreement, though the specific financial impact and original purpose are not detailed in the filing.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-28
Item 8.01
Cycurion announced closed public safety contracts expected to generate $843,028 in 2026 revenue, including a City of Chicago contract with a projected 10-year CAD administration value of $3.43 million. The company also referenced pending Nasdaq delisting appeal proceedings and product development initiatives.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-28
Item 8.01
The disclosure reports a third extension payment of $67,500 from CPRO Korea pursuant to a merger agreement dated May 22, 2026, which extends the deadline to consummate the initial business combination by one month (from October 1 to November 1, 2026). This is a material update to an ongoing M&A transaction that affects the timing and status of the merger, which is central to a SPAC's purpose and would materially affect investor assessment of the transaction's progress.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-28
Item 5.02
Jason Secore's appointment as Chief Financial Officer effective September 30, 2026, is the principal disclosed action. While Oliver Reeves' departure is also disclosed, the filing centers on Secore's appointment with detailed disclosure of his background, compensation package (including $450,000 base salary, equity grants totaling 790,000 units, and severance terms), and his designation as Principal Financial Officer and Principal Accounting Officer. This is a material C-suite appointment at a public company.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-25
Item 5.02
The filing discloses awards of time-based RSUs and performance-based PSUs to executive officers (CEO, CFO, SVP, Chief Procurement Officer, and General Counsel) under the 2026 Omnibus Incentive Plan, together with a separate 150,000 RSU award to CEO Jonathan DeGaynor with a five-year cliff vest. This is a classic executive compensation disclosure under Item 5.02(e), involving equity grants and compensatory arrangements rather than departures or appointments. The awards are material to investors as they represent significant long-term incentive compensation and retention mechanisms for named executives.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-09-25
Item 5.02
AllianceBernstein announced the appointment of Onur Erzan as President and Chief Executive Officer, effective April 1, 2027, with total compensation target of $13.5 million for 2027 and specified severance provisions. The appointment represents a significant leadership transition at the major asset manager, with Seth Bernstein retiring as CEO effective March 31, 2027.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 88%
filed 2026-09-25
Item 1.01
Dynex Capital entered into an underwriting agreement on September 22, 2026, to issue 4,800,000 shares of 9.375% Series D Fixed-Rate Cumulative Redeemable Preferred Stock with a liquidation preference of $25.00 per share, generating approximately $116.2 million in net proceeds. Although structured as preferred stock, these securities function as debt-like instruments with fixed dividend rates and liquidation preferences, creating a direct financial obligation material to the REIT's capital structure.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-25
Item 1.02
Hartford received a $1.12 billion cash payment upon commutation and termination of a long-standing reinsurance agreement with NICO (Berkshire Hathaway subsidiary) covering asbestos and environmental adverse development. The transaction resulted in a before-tax net gain of $497 million and increased net income of $393 million, materially improving Hartford's financial position and resolving a decade-long reinsurance relationship and related arbitration dispute.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-25
Item 1.01
Titan International entered into a definitive Sale and Purchase Agreement to sell its wholly-owned subsidiary Italtractor ITM S.p.A. to USCO S.p.A. for approximately $207 million in cash plus up to $6 million in earnout payments and approximately $23 million in net asset adjustments, totaling approximately $285 million in expected proceeds. The transaction is expected to close in January 2027 and represents a material disposition of a significant global undercarriage components business unit.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-25
Item 1.01
Essex Property Trust entered into a $275 million Unsecured Term Loan Agreement with Bank of America and other lenders on September 24, 2026, with a three-year maturity and extension options. The proceeds are intended to repay commercial paper and fund general corporate purposes.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 94%
filed 2026-09-25
Item 3.01
Lumen Technologies announced a voluntary transfer of its common stock listing from the NYSE to Nasdaq, with delisting from NYSE effective October 5, 2026, and listing on Nasdaq effective October 6, 2026. While this is a planned, voluntary transition rather than a distress-driven delisting, it constitutes a material transfer of listing that affects trading venue and market accessibility for investors.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-25
Item 1.01
This disclosure reports entry into a material definitive agreement under Item 1.01. MARA's subsidiary Volt Texas LLC acquired all membership interests in MAT 1177 LLC (the Project Company) on July 2, 2026, with a total purchase price of $600 million structured as milestone payments. The filing further discloses a First Amendment on September 21, 2026, restructuring milestone payments and introducing a $100 million security deposit with an electric utility company. The transaction involves acquisition of a data center project with significant power capacity rights in Texas, representing a material acquisition activity that would affect a reasonable investor's assessment of the company's strategic direction and capital deployment.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-09-25
Item 8.01
Open Text amended terms of a cash tender offer for its 3.875% Senior Notes due 2028, reducing the aggregate maximum tender amount from $450 million to $300 million and extending key deadlines. While this is technically a modification of an existing debt obligation rather than creation of new debt, the tender offer represents a material restructuring of the company's debt capital structure. The company is using proceeds from a concurrent senior secured notes offering to fund the tender, indicating material capital activity. This is most appropriately classified as debt_issuance given the material financial obligation and capital restructuring involved.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-25
Item 5.02
Heidi L. O'Neill resigned from the Board of Directors of Lithia Motors, Inc., effective September 25, 2026. The disclosure centers on a director's departure for personal reasons, with no disagreement with the Company. Board departures are material governance events affecting the composition of the registrant's leadership.
View raw filing on EDGAR →
8-K
Restatement
confidence 95%
filed 2026-09-25
Item 4.02
The filing explicitly discloses that the Audit Committee concluded on September 22, 2026, that previously issued audited consolidated financial statements for the years ended December 31, 2025 and 2024, and unaudited condensed consolidated financial statements for the three-month periods ended March 31, 2026 and 2025, "should be restated" and "should no longer be relied upon." The restatement addresses incorrect accounting classification and measurement of Series A Preferred Stock and Senior Preferred Stock under ASC 480-10-S99-3A, and management identified a material weakness in internal controls over financial reporting related to accounting for equity instruments. Although the restatement had no effect on total assets, liabilities, revenues, net loss, or EPS, the disclosure of non-reliance on previously issued financial statements is the hallmark of a restatement event under Item 4.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-09-25
Item 2.02
Ferrellgas Partners disclosed fourth quarter and full fiscal year 2026 financial results as of July 31, 2026, reporting Adjusted EBITDA of $321.3 million (down 3% from prior year) and net earnings of $71.7 million, compared to a net loss of $15.6 million in fiscal 2025.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-25
Item 5.02
Joyce Mullen was appointed to Duke Energy's Board of Directors effective September 28, 2026, and simultaneously appointed to the Audit Committee and Operations and Nuclear Oversight Committee. Her qualifications include former CEO of Fortune 500 Insight Enterprises and 21-year tenure at Dell Technologies, with expertise in AI, digital innovation, and customer-focused execution.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-25
EX-99.1
Fresenius Medical Care announced a strategic refinement of its China commercial operations, including discontinuation of the 4008A hemodialysis system and exit from the peritoneal dialysis business, coupled with one-time charges of approximately €110 million (primarily impairment and termination costs) to be recognized in Q3 2026. This is a material operational and strategic business decision affecting a significant market segment (6-7% of Care Enablement revenues) with quantifiable financial impact, but does not fit the specific categories of workforce_reduction, material_impairment (standalone), or ma_activity; it is best classified as a material operational restructuring with strategic portfolio optimization.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-25
Item 5.02
Cencora appointed Robert E. Sanchez, former CEO of Ryder System, Inc., to its Board of Directors effective October 1, 2026, expanding the Board from ten to eleven members. Mr. Sanchez brings significant public-company leadership experience in logistics and supply chains, and the Board Chair and CEO highlighted the strategic value his appointment brings to the company's growth ambitions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-25
Item 5.02
The Board of Directors elected Pamela J. Shelley-Kessler and Clint B. Malin to the Board on September 22, 2026, increasing the Board size from six to eight members. Both individuals are the Company's Co-Presidents and Co-CEOs (since December 2024), and the disclosure emphasizes their instrumental roles in building and scaling the Company's SHOP platform and reshaping LTC's strategic direction. This is a material appointment of two senior executives to the Board, reflecting their elevated governance roles.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-25
Item 1.01
Porsche Auto Funding LLC and Porsche Financial Services entered into an Underwriting Agreement with Wells Fargo Securities for the issuance of $911 million in aggregate principal balance of securitized notes (Class A-1 through A-4) by Porsche Financial Auto Securitization Trust 2026-1, supported by a transfer of retail motor vehicle installment sales contracts under a Sale and Servicing Agreement with U.S. Bank Trust Company as indenture trustee, with anticipated closing on September 30, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-25
Item 8.01
The registrant has issued $911 million in aggregate principal amount of asset-backed notes across five classes (Class A-1 through A-4) by Porsche Financial Auto Securitization Trust 2026-1. This constitutes creation of direct financial obligations through debt issuance, disclosed via prospectus dated September 23, 2026. The 8-K filing documents the issuance and attaches required legality and tax opinions from counsel.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 85%
filed 2026-09-25
The 6-K announces the redemption and coupon payment of a TRY 500,000,000 financing bond (ISIN TRFTCEL92628) with a 93-day maturity and 40.25% annual interest rate, completed on September 25, 2026. While technically a redemption event, the disclosure is fundamentally about the issuance and terms of this debt instrument—a material direct financial obligation created by the registrant. The detailed terms (nominal amount, interest rate, maturity, intermediary, and rating) are characteristic of debt-issuance disclosure under Item 2.03 equivalent.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 85%
filed 2026-09-25
The 6-K announces the redemption and coupon payment of a TRY 500 million financing bond (ISIN TRFTCEL92610) with a 93-day maturity and 40.25% annual interest rate, completed on September 25, 2026. While technically a redemption (repayment) rather than issuance, the disclosure documents the full lifecycle of a material debt instrument—its terms, pricing, and final payment—and represents a significant capital market transaction. The materiality is evident from the nominal amount (TRY 500 million), the high interest rate reflecting market conditions, and the formal regulatory disclosures required by Turkish capital markets authorities.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-09-25
Item 5.02
Rob Gehring, Chief Executive Officer of Monster Energy Company's Americas division, resigned effective November 30, 2026, to join The Coca-Cola Company as president of its North America operating unit. While the filing also discloses Emelie C. Tirre's interim appointment to assume his responsibilities, the principal disclosed action centers on Gehring's departure from a senior executive role overseeing a major geographic segment.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-25
Item 5.02
The Board adopted the BKV Corporation Executive Severance Plan on September 24, 2026, establishing compensatory arrangements for named executive officers and other participants. The disclosure details severance benefits including cash payments (base salary plus bonus multiples), equity vesting provisions, healthcare premium coverage, and bonus payments—all classic elements of executive compensation arrangements. While Item 5.02 encompasses departures and appointments, the substantive disclosure here centers on the creation of a new severance compensation plan, not on any individual's departure or appointment.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-09-25
Item 8.01
NextCure filed a Section 205 petition in Delaware Court of Chancery seeking validation of a 2025 reverse stock split amendment that may have been approved under an incorrect voting standard. This is a governance matter involving potential defects in a corporate act (the reverse split) and uncertainty about capitalization, which could impair the pending business combination with Avere. While not a standard governance category (not an exec change, auditor change, or shareholder vote result), it is clearly a material governance/corporate law issue affecting the validity of the company's capital structure and requiring court validation.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-25
Item 1.01
Sysco Corporation and Sysco Holdings Corporation issued C$1.5 billion in aggregate principal amount of senior notes (C$750 million 4.250% Notes due 2030 and C$750 million 4.800% Notes due 2034) on September 25, 2026, with net proceeds of approximately C$1.49 billion intended to finance the pending acquisition of JRD Unico, Inc. and Warehouse Realty, LLC.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-09-25
Ms. Chunfang (Vicky) Gu resigned from her position as Executive Director of Finance, effective September 30, 2026. This is a departure of a named executive officer responsible for finance functions. While the resignation is attributed to personal reasons with no disagreement with the board, the departure of a finance executive is material to investors' assessment of the company's financial oversight and governance.
View raw filing on EDGAR →
8-K
Financial Other
confidence 72%
filed 2026-09-25
Item 1.02
Riot Platforms completed full voluntary prepayment and termination of a $200 million secured credit facility with Coinbase Credit on September 21, 2026. While Item 1.02 addresses termination of material definitive agreements, this disclosure centers on debt repayment and facility termination rather than a traditional M&A or strategic transaction. The prepayment eliminates a material financial obligation and releases security interests in the Company's crypto assets (bitcoin, USDC, cash), making it a significant financial event. This is best classified as financial_other rather than debt_issuance (which addresses creation of obligations) or ma_activity (which typically involves acquisitions or dispositions of business units).
View raw filing on EDGAR →
6-K
Restatement
confidence 98%
filed 2026-09-25
The filing explicitly discloses non-reliance on previously issued audited financial statements for the years ended December 31, 2025 and 2024, and unaudited interim financial information for the quarterly period ended June 30, 2026. The Company identified non-cash valuation errors in stock option accounting and warrant liability accounting, requiring restatement of the Affected Financials. This is a classic restatement disclosure under Item 4.02 equivalent, materially affecting investor confidence in reported financial results.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 85%
filed 2026-09-25
Item 5.02
Texas Pacific Land Corp amended employment agreements for three named executives—Tyler Glover (President and CEO), Chris Steddum (CFO), and Micheal W. Dobbs (SVP/General Counsel)—extending their contract terms from December 31, 2026 to December 31, 2029 with automatic one-year renewals, reflecting a material modification to executive compensatory arrangements and employment continuity.
View raw filing on EDGAR →
8-K
Governance Other
confidence 82%
filed 2026-09-25
Item 3.03
AerSale Corporation completed a redomestication from Delaware to Texas on September 25, 2026, following stockholder approval at the June 2026 Annual Meeting. The redomestication materially altered the company's governing law and charter documents, changing stockholder rights and governance structure from Delaware to Texas law. A legal opinion supporting the redomestication was filed as Exhibit 5.1.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 95%
filed 2026-09-25
Item 2.05
The Company disclosed multiple restructuring initiatives involving workforce reductions across multiple facilities and business units, facility consolidations, and operational relocations, with aggregate severance costs of approximately $5.6 million in non-recurring pre-tax charges and projected annualized cost savings of $10.8 million, with implementation substantially complete by end of fiscal 2027.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-09-25
Item 5.02
The Compensation Committee approved special, one-time restricted stock unit awards to three named executives (Anselm Wong, Morgan Hodges, and Vic Nettie), each with a grant date value of $750,000, vesting over three years contingent on continued employment, designed for retention and stockholder alignment purposes.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-09-25
Item 7.01
The Board declared a material warrant distribution to Class B Common Stock holders as of October 5, 2026, with approximately 470 million warrants to be issued on October 13, 2026 on a 1:1 basis, contingent on closing of the Warner Bros. Discovery acquisition. The warrants are expected to trade separately on NYSE and represent a capital event affecting shareholder value and ownership structure.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-09-25
Item 3.01
The filing discloses a formal notice from NYSE Regulation that the Company has fallen below the continued listing standard (average aggregate global market capitalization of $40 million over 30 trading days) and that delisting proceedings have commenced under Section 802.01B of the NYSE Listed Company Manual. Trading has been suspended and securities will move to OTC markets, representing a material loss of liquidity and market access that would significantly affect investor assessment of the registrant.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-09-25
Tidewater entered into a Guarantee Agreement on September 21, 2026, whereby it guarantees the full and timely payment of all borrower obligations under BNDES Construction Loans. The guarantee constitutes an unsecured direct financial obligation of the registrant that ranks pari passu with other unsecured obligations. Item 2.03 explicitly incorporates the Item 1.01 disclosure, confirming this is a "Creation of a Direct Financial Obligation." While technically a guarantee rather than a new debt issuance, it creates a material contingent liability that would affect investor assessment of the company's financial obligations.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-25
Item 5.02
Onur Erzan was appointed President and Chief Executive Officer of AllianceBernstein, effective April 1, 2027, succeeding Seth Bernstein who retired as CEO effective March 31, 2027. The appointment represents a significant leadership transition at the major global investment management firm, with Erzan assuming the role after serving as President.
View raw filing on EDGAR →